Cleveland Clinic-led research employs advanced image analysis to inform dose delivery
Predicts drug response in patient with rare, aggressive cancer
Moving radiotherapy beyond a one-size-fits-all approach
Researchers identify genetic basis for cancer cells’ susceptibility to DNA damage
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
MEK inhibitors can render them vulnerable to radiation
Researchers study impact of genomic determinants
Large-scale Cleveland Clinic effort catalogues and targets genetic alterations that confer resistance